Experience of the Eliava Institute in bacteriophage therapy

<正>The rapid propagation of multidrug resistant bacterial strains is leading to renewed interest in bacteriophage therapy.With challenges in the treatment of bacterial infections,it is essential for people worldwide to understand how alternative approaches,such as bacteriophages,could...

Full description

Saved in:
Bibliographic Details
Published inVirologica Sinica Vol. 30; no. 1; pp. 80 - 81
Main Author Kutateladze, Mzia
Format Journal Article
LanguageEnglish
Published Heidelberg Wuhan Institute of Virology, CAS 01.02.2015
Subjects
antibiotic
Bacteria - virology
Bacterial Infections - microbiology
Bacterial Infections - therapy
Bacteriophages - genetics
Bacteriophages - isolation & purification
Bacteriophages - physiology
Biochemistry
Biological Therapy - history
Biomedical and Life Sciences
Biomedicine
challenges
combat
currently
facility
Figure
Georgia (Republic)
History, 20th Century
History, 21st Century
Humans
Insight
Medical Microbiology
Microbial Genetics and Genomics
Microbiology
Oncology
phage
preparations
renewed
Virology
Georgia (Republic)
Phage Preparation
Quality Control Production
Resistant Bacterial Strain
VIROLOGICA SINICA
Phage Therapy
Online AccessGet full text

Cover

More Information
Summary:<正>The rapid propagation of multidrug resistant bacterial strains is leading to renewed interest in bacteriophage therapy.With challenges in the treatment of bacterial infections,it is essential for people worldwide to understand how alternative approaches,such as bacteriophages,could be used to combat antibiotic resistant bacteria.The Eliava Institute
Bibliography:42-1760/Q
Mzia Kutateladze;George Eliava Institute of Bacteriophages, Microbiology and Virology
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1674-0769
1995-820X
1995-820X
DOI:10.1007/s12250-014-3557-0